CalciMedica Inc reports results for the quarter ended in January - Earnings Summary

Calcimedica

13/05/2024 22:25

* CalciMedica Inc  CALC.OQ  reported quarterly adjusted
earnings
of 1 cent​​ per share for the quarter ended in January, higher
than the same quarter last year, when the company reported EPS
of $-23.43.  The mean expectation of four analysts for the
quarter was for a loss of 67 cents per share. Wall Street
expected results to range from $-1.22 to -45 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * CalciMedica Inc's reported EPS for the quarter was 1
cent​.
    * The company reported quarterly net income of $130
thousand.
    * CalciMedica Inc shares had risen by 34.6% this quarter and
gained 95.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 6.9%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for CalciMedica Inc
is $17.00 
This summary was machine generated from LSEG data May 13 at
09:25 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.67          0.01           Beat
 Dec. 31 2023      -0.87          -0.23          Beat
 Sep. 30 2023      -1.14          -0.82          Beat
 Jun. 30 2023      -1.04          -1.11          Missed